- Home
- MARA vs MRUS Comparison
MARA vs MRUS Comparison
Compare MARA & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARA
- MRUS
- Stock Information
- Founded
- MARA 2010
- MRUS 2003
- Country
- MARA United States
- MRUS Netherlands
- Employees
- MARA N/A
- MRUS N/A
- Industry
- MARA EDP Services
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- MARA Technology
- MRUS Health Care
- Exchange
- MARA Nasdaq
- MRUS Nasdaq
- Market Cap
- MARA 5.6B
- MRUS 5.1B
- IPO Year
- MARA N/A
- MRUS 2016
- Fundamental
- Price
- MARA $17.47
- MRUS $67.34
- Analyst Decision
- MARA Buy
- MRUS Strong Buy
- Analyst Count
- MARA 14
- MRUS 13
- Target Price
- MARA $23.29
- MRUS $90.92
- AVG Volume (30 Days)
- MARA 57.7M
- MRUS 596.7K
- Earning Date
- MARA 11-11-2025
- MRUS 10-30-2025
- Dividend Yield
- MARA N/A
- MRUS N/A
- EPS Growth
- MARA 85.33
- MRUS N/A
- EPS
- MARA 1.74
- MRUS N/A
- Revenue
- MARA $798,410,000.00
- MRUS $56,228,000.00
- Revenue This Year
- MARA $53.87
- MRUS $57.42
- Revenue Next Year
- MARA $28.51
- MRUS $0.23
- P/E Ratio
- MARA $9.36
- MRUS N/A
- Revenue Growth
- MARA 41.32
- MRUS 59.77
- 52 Week Low
- MARA $9.81
- MRUS $33.19
- 52 Week High
- MARA $30.28
- MRUS $70.65
- Technical
- Relative Strength Index (RSI)
- MARA 53.67
- MRUS 53.24
- Support Level
- MARA N/A
- MRUS $66.49
- Resistance Level
- MARA $16.64
- MRUS $70.65
- Average True Range (ATR)
- MARA 0.75
- MRUS 2.54
- MACD
- MARA -0.40
- MRUS -0.08
- Stochastic Oscillator
- MARA 99.86
- MRUS 57.79
About MARA Marathon Digital Holdings Inc.
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.